Residual Dyslipidemia Leads to Unfavorable Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention by Bin Que, Chunmei Wang, Hui Ai, Xinyong Zhang, Mei Wang, Shaoping Nie

“…The present study aimed to evaluate the prevalence and prognosis of residual lipid abnormalities in statin-treated acute coronary syndrome (ACS) patients after percutaneous coronary intervention (PCI). …”
Get full text

Almanac 2015: coronary artery disease by D. Shavelle

“…These include assessment of novel biomarkers and imaging methods for patients at risk for coronary artery disease, care of patients with ST-segment elevation myocardial infarction, a novel device to treat medical refractory angina, use of non-statin lipid-lowering agents, a better understanding of the risks and benefits of longterm dual antiplatelet therapy and the use of the newer antiplatelet agents. …”
Get full text

Severe Rhabdomyolysis Associated with Simvastatin and Role of Ciprofloxacin and Amlodipine Coadministration by Nicolas De Schryver, Xavier Wittebole, Peter Van den Bergh, Vincent Haufroid, Eric Goffin, Philippe Hantson

“…Simvastatin is among the most commonly used prescription medications for cholesterol reduction and the most common statin-related adverse drug reaction is skeletal muscle toxicity. …”
Get full text

Impact of duration of treatments with metformin and sulfonylureas, individually or in combination, on diabetic retinopathy among newly diagnosed type 2 diabetic patients: a pooled... by Mansour Bahardoust, Yadollah Mehrabi, Farzad Hadaegh, Davood Khalili, Ali Delpisheh

“…The cumulative exposure to metformin, SUs, aspirin, statin, and anti-hypertensive medication was also determined using the same approach. …”
Get full text

Pure White Cell Aplasia and Necrotizing Myositis by Peter Geon Kim, Joome Suh, Max W. Adelman, Kwadwo Oduro, Erik Williams, Andrew M. Brunner, David J. Kuter

“…These findings were associated with a recent course of azithromycin and her daily use of a statin. Myositis improved on prednisone but PWCA persisted. …”
Get full text

Effect of PCSK9 inhibitor on early neurological deterioration in acute ischemic stroke patients with a history of coronary heart disease: a study protocol for a randomized controll... by Xing Gong, Xinting Yu, Lanlan Pu, Yang Jiao, Lin Liu, Hua Cao, Xiaofei Ji

“…A total of 156 AIS patients with a history of CHD and within 24 h from symptom onset will be recruited and randomized in a 1:1 allocation to either the PCSK9 inhibitor combined with statin treatment group (PI group) or the statin monotherapy group (AT group). …”
Get full text

Adolescent with Rhabdomyolysis due to Undiagnosed Hypothyroidism by Raquel Farias Moeller, Nassim Zecavati, Rosa Sherafat-Kazemzadeh, Shoshana Aleinikoff, Wolfgang Rennert

“…Exercise-induced rhabdomyolysis has been described in military recruits, trained athletes and daily runners. Statin use, quail ingestion, infection by Epstein-Barr virus (EBV), and hypothyroidism, though rare, are risk factors for the development of rhabdomyolysis. …”
Get full text

Role of high-density lipoprotein cholesterol in health and diseases by Brijesh Yadav, Narayan Prasad

“…In this review, we have discussed the different property of high-density lipoprotein cholesterol, its function and factors influencing HDLc property in light of anti-inflammatory activity in rheumatoid arthritis and the role of cholesterol-lowering statin drug in enhancing the beneficial effect of high-density lipoprotein cholesterol in different cell types.…”
Get full text

MANAGEMENT OF TYPE 2 DIABETES by Maitham Abdallah Albajy, Dan Florin Mihailescu

“…While SGLT2 inhibitors and GLP1 agents offer cardiovascular benefits, they should complement, not replace, statin therapy and blood pressure control for effective cardiovascular risk reduction.…”
Get full text

Diabetes and Stroke Prevention: A Review by Jonathan Hewitt, Luis Castilla Guerra, María del Carmen Fernández-Moreno, Cristina Sierra

“…Lipids should be treated with a statin whatever the starting cholesterol. Antiplatelet treatment is also essential but there are no specific recommendations for the diabetic person. …”
Get full text

Lovastatin Decreases the Expression of CD133 and Influences the Differentiation Potential of Human Embryonic Stem Cells by Ade Kallas-Kivi, Annika Trei, Toivo Maimets

“…The lipophilic statin lovastatin decreases cholesterol synthesis and is a safe and effective treatment for the prevention of cardiovascular diseases. …”
Get full text

The Role of Angiotensin Antagonism in Coronary Plaque Regression: Insights from the Glagovian Model by Abdul H. Alkatiri, Doni Firman, Amir A. Alkatiri, Paskalis I. Suryajaya, Albert Sudharsono

“…Significant coronary atheromatous plaque regression has been previously demonstrated in various studies using statin agents. Similar results have been reported in different studies using angiotensin inhibitor agents, notably ARB agents. …”
Get full text

Nitric Oxide in Cerebral Vasospasm: Theories, Measurement, and Treatment by Michael Siuta, Scott L. Zuckerman, J. Mocco

“…Recent evidence indicates that targeting NOS dysfunction, for example, through erythropoietin or statin administration, also shows promise at preventing vasospasm and neurotoxicity. …”
Get full text

Differences Between Lovastatin and Simvastatin Hydrolysis in Healthy Male and Female Volunteers: Gut Hydrolysis of Lovastatin is Twice that of Simvastatin by Tom B. Vree, Erik Dammers, Ivan Ulc, Stefan Horkovics-Kovats, Miroslav Ryska, IJsbrand Merkx

“…This study was based on the plasma concentration-time curves and the pharmacokinetics of lovastatin and simvastatin with its respective active metabolite statin-β-hydroxy acid obtained from two different bioequivalence studies, each with 18 females and 18 males. …”
Get full text

Left ventricular clot mysteries: A case report of vanishing left ventricular clot and role of multimodality imaging in a patient presenting with ischemic cerebrovascular stroke by Susheel K. Malani, Chigullapalli Sridevi, Digvijay Nalawade, Prakash Chaudhary, Ankit Shokeen, Gauri Maheshwari

“…He was on treatment for that as single antiplatelet and statin. He was evaluated for young CVA by the neurology department and he was referred for cardiac evaluation to rule out the cardioembolic stroke. …”
Get full text

The Role of Coenzyme Q10 in Modern Medicine: Insights into Energy Metabolism and Antioxidant Therapy by Mateusz Górski, Adrianna Załęska, Mateusz Bychowski, Julia Kwaśna, Izabela Kaźmierczyk, Kacper Lenart, Michał Homza, Natalia Zakrzewska, Szymon Bednarek, Joanna Kulicka

“…Promising but inconclusive evidence supports its role in managing statin-induced myopathy and enhancing reproductive outcomes. …”
Get full text

A Rare Cause of Secondary Amyloidosis: Common Variable Immunodeficiency Disease by Ali Kemal Kadiroğlu, Yaşar Yıldırım, Zülfükar Yılmaz, Hasan Kayabaşı, Yahya Avcı, M. Serdar Yıldırım, M. Emin Yılmaz

“…A treatment regimen (an ACE inhibitor and a statin) with monthly administration of intravenous immunoglobulin was started.…”
Get full text

Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis by Aldo Bonaventura, François Mach, Aline Roth, Sébastien Lenglet, Fabienne Burger, Karim J. Brandt, Aldo Pende, Maria Bertolotto, Giovanni Spinella, Bianca Pane, Domenico Palombo, Franco Dallegri, Michele Cea, Nicolas Vuilleumier, Fabrizio Montecucco, Federico Carbone

“…This risk of MACEs increased independently of age, male gender, serum CRP, and statin use. In conclusion, in patients with severe carotid artery stenosis, high CRP levels within upstream portions of carotid plaques directly and positively correlate with intraplaque inflammatory cells and predict MACEs at an 18-month follow-up period.…”
Get full text

Serum Lipids Alterations in Patients Under Systemic JAK Inhibitors Treatments in Dermatology: Clinical Aspects and Management by Giovanni Paolino, Mario Valenti, Andrea Carugno, Matteo Bianco, Dario Didona, Matteo Riccardo Di Nicola, Pier Luigi Acutis, Carmen Cantisani, Vittoria Giulia Bianchi, Nicola Zerbinati, Alessandra Narcisi, Antonio Costanzo, Santo Raffaele Mercuri

“…Monitoring lipid levels, alongside lifestyle modifications and possible statin use, can manage these effects without the need to stopping treatment.…”
Get full text

Creating National Weights for a Patient-level Longitudinal Database by Onur Baser, Li Wang, Jon Maguire

“…The annual number of statin users were predicted as 6 709 438 using weighted MEPS data. …”
Get full text